Double Bond aims at adaptive design for SI-053 Phase I

By |2018-11-20T23:39:15+01:00November 19th, 2018|

Double Bond aims at adaptive design for SI-053 Phase I FRI, MAY 04, 2018 10:19 CET Double Bond Pharmaceutical (DBP) has signed a service contract with Cytel Inc, a leading provider of clinical research services and software, to develop an adaptive model-based study design for [...]